Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ALT5 Sigma (ALTS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for ALT5 Sigma (ALTS) over the last 16 years, with Q3 2025 value amounting to $7.3 million.

  • ALT5 Sigma's Cash & Equivalents fell 1558.43% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year decrease of 1558.43%. This contributed to the annual value of $7.2 million for FY2024, which is 14344000.0% up from last year.
  • According to the latest figures from Q3 2025, ALT5 Sigma's Cash & Equivalents is $7.3 million, which was down 1558.43% from $9.6 million recorded in Q2 2025.
  • In the past 5 years, ALT5 Sigma's Cash & Equivalents registered a high of $10.8 million during Q1 2025, and its lowest value of $5000.0 during Q4 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $1.7 million (2022), whereas its average is $3.4 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 9180.33% in 2023, then skyrocketed by 14344000.0% in 2024.
  • ALT5 Sigma's Cash & Equivalents (Quarter) stood at $2.8 million in 2021, then tumbled by 97.84% to $61000.0 in 2022, then plummeted by 91.8% to $5000.0 in 2023, then skyrocketed by 143440.0% to $7.2 million in 2024, then rose by 1.96% to $7.3 million in 2025.
  • Its Cash & Equivalents stands at $7.3 million for Q3 2025, versus $9.6 million for Q2 2025 and $10.8 million for Q1 2025.